Steven Pfeiffer
Chief Tech/Sci/R&D Officer at ODONATE, INC.
Profile
Steven Pfeiffer is currently working as the Senior Vice President-Technical Operations at Odonate, Inc. He previously worked as the Associate Director-Product Research & Development at Kythera Biopharmaceuticals LLC from 2011 to 2015.
From 2015 to 2016, he held the position of Senior Director-Manufacturing & Development at Horizon Therapeutics Plc.
Prior to that, he was an Associate Director at SAI Life Sciences Ltd.
from 2009 to 2010.
Dr. Pfeiffer started his career as a Research Scientist at Gilead Sciences, Inc. from 2005 to 2009.
He holds an MBA from California State University-East Bay, an undergraduate degree from the University of Arizona, and a doctorate from the University of California, Santa Barbara.
Steven Pfeiffer active positions
Companies | Position | Start |
---|---|---|
ODONATE, INC. | Chief Tech/Sci/R&D Officer | 2016-07-31 |
Former positions of Steven Pfeiffer
Companies | Position | End |
---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 2015-12-31 |
KYTHERA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 2014-12-31 |
SAI Life Sciences Ltd.
SAI Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology SAI Life Sciences Ltd. manufactures, develops, and discovers pharmaceutical drugs. The company was founded in 1999 and is headquartered in Hyderabad, India. | Corporate Officer/Principal | 2009-12-31 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2008-12-31 |
Training of Steven Pfeiffer
University of California, Santa Barbara | Doctorate Degree |
California State University-East Bay | Masters Business Admin |
University of Arizona | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ODONATE, INC. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
Private companies | 3 |
---|---|
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Kythera Biopharmaceuticals LLC
Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
SAI Life Sciences Ltd.
SAI Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology SAI Life Sciences Ltd. manufactures, develops, and discovers pharmaceutical drugs. The company was founded in 1999 and is headquartered in Hyderabad, India. | Health Technology |
- Stock Market
- Insiders
- Steven Pfeiffer